Sponsor pipeline

University of Michigan Rogel Cancer Center clinical trial pipeline

Get alerts when University of Michigan Rogel Cancer Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

11 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 5 with minor changes only.

  1. Notable

    Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy

    Phase changed: Phase 1 → not applicable

    Also in this update: Primary completion moved earlier from May 2028 to Dec 31, 2026; Study completion moved earlier from Nov 2028 to Jun 30, 2028

    University of Michigan Rogel Cancer CenterNot applicable NCT04518748 Registry history of NCT04518748 on ClinicalTrials.gov (opens the registry)

Show 5 trials with minor changes only
  1. Minor

    Ribociclib Administered Concurrently With Postoperative Radiation Therapy · High-Risk, HR+/HER2- Breast Cancer

    Enrollment closed, study ongoing

    Also in this update: Primary completion pushed from Oct 2026 to Feb 2027; Study completion moved earlier from Oct 2030 to Feb 2030

    University of Michigan Rogel Cancer CenterPhase 1 NCT05996107 Registry history of NCT05996107 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-08 NCT07864792 Transcranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who… Not Yet Recruiting

Active trials by phase

Early Phase 1
1
Phase 1
7
Phase 1/2
5
Phase 2
20
Phase 4
1
Not charted: 29 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 29

Get alerts when University of Michigan Rogel Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free